Division of Endocrinology, Diabetes and Clinical Nutrition, Department of Medicine, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Mailcode L607, Portland, OR, 97239-3098, USA,
Endocrine. 2013 Oct;44(2):283-92. doi: 10.1007/s12020-013-9893-2. Epub 2013 Feb 2.
Adrenal insufficiency (AI) in pregnancy is relatively rare, but it is associated with significant maternal and fetal morbidity and mortality if untreated during gestation or in the puerperium. Hence, timely diagnosis and decisive treatment by the clinician are critical. However, due to pregnancy-induced metabolic and endocrine changes and the resemblance of symptomatology of AI to those of pregnancy, the diagnosis is often difficult to recognize and challenging to confirm. Normal pregnancy is a state of glucocorticoid excess particularly in the latter stages, and normative values for serum cortisol levels are not well-established. Furthermore, testing the hypothalamic-pituitary-adrenal axis using validated stimulation tests during pregnancy are lacking. Therefore, it is the aim of the present review to discuss and to summarize the current knowledge, focussing on the challenges in recognizing AI in pregnancy and interpreting the diagnostic tests, and to propose a clinical approach for optimizing the management of AI in women diagnosed before or during pregnancy.
妊娠合并肾上腺功能不全(AI)相对少见,但如果在妊娠期或产褥期未得到治疗,会导致母婴发病率和死亡率显著增加。因此,临床医生及时诊断和果断治疗至关重要。然而,由于妊娠引起的代谢和内分泌变化以及 AI 症状与妊娠的相似性,其诊断常常难以识别,难以确诊。正常妊娠是一种糖皮质激素过多的状态,特别是在妊娠后期,血清皮质醇水平的正常值尚未确定。此外,在妊娠期间使用经过验证的刺激试验来检测下丘脑-垂体-肾上腺轴也缺乏。因此,本综述的目的是讨论和总结目前的知识,重点是探讨在妊娠期间识别 AI 以及解释诊断试验时所面临的挑战,并提出一种临床方法,以优化对诊断为妊娠前或妊娠期间的 AI 患者的管理。